Several human studies describe altered Reelin levels in AD: notably, the 180 kDa N-terminal Reelin fragment is significantly elevated in the cerebrospinal fluid (CSF) of AD patients compared to those with mild cognitive impairment (MCI) or healthy controls [8]. The gene discussed is RELN; the disease is Alzheimer disease.